Chikungunya virus infection in Indonesia: a systematic review and evolutionary analysis

BMC Infectious Diseases

Table 3 Seroprevalence of anti-Chikungunya virus IgG antibodies within certain Indonesian location as reported in published papers

Setting	Year	Region	Sample tested	Positive cases		Diagnosis method	Reference
Setting	Year	Region	Sample tested	Number	%	Diagnosis method	Reference
Non-outbreak and febrile	2004–2005	Indonesia	198	87	43.9	IgG	[77]
	1995–1996	Semarang	60	14	23.3	IgG	[79]
	1998–1999	Yogyakarta	57	24	42.1	IgG	[54]
Non-outbreak and non-febrile	1998–1999	Yogyakarta	123	33	26.8	IgG	[55]
	2002	Bekasi	55	3	5.4	IgG	[55]
	2001	Bogor	99	13	13.1	IgG	[55]
	1972	Kalimantan	692	151	21.8	HI	[50]
	1972	Java	54	0	0.0	HI	[51]
	1972	Bali	107	2	1.9	HI	[51]
	1972	Lombok	140	6	4.3	HI	[51]
	1972	Kupang	121	15	12.4	HI	[51]
	1972	Sulawesi	298	55	18.4	HI	[51]
	1972	Ambon	321	37	11.5	HI	[51]
	1972	Kalimantan	199	28	14.1	PRNT	[50]
	1971	Sulawesi	125	24	19.2	PRNT	[50]
	1971	Ambon	64	2	3.1	PRNT	[50]
	1969–1970	Papua	243	45	18.5	PRNT	[50]
Median (Non-outbreak)	1969–2005	Indonesia			14.1 (0.0–43.9)		Present study
Outbreak and febrile	2015	Bali	8	0	0.0	IgG	[79]
	2002–2003	North Sulawesi	222	18	8.1	IgG	[56]
	2002	Bekasi	93	68	73.1	IgG	[56]
	2001	Bogor	86	58	67.4	IgG	[56]
	1998–1999	Yogyakarta	61	43	70.4	IgG	[55]
Outbreak and non-febrile	2002	Bekasi	145	65	44.8	IgG	[56]
	2001	Bogor	70	35	50.0	IgG	[56]
	1998–1999	Yogyakarta	76	34	44.5	IgG	[55]
Median (Outbreak)	1998–2015	Indonesia			47.4 (0.0–73.1)		Present study
Median (Total)	1969–2015	Indonesia			18.5 (0.0–73.1)		Present study

HI Haemagglutination inhibition assay, IgG Immunoglobulin G, PRNT Plaque reduction neutralization tests

ISSN: 1471-2334